Attenuation of hypocretin/orexin signaling is associated with increased mortality after myocardial infarction
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F23%3A00083895" target="_blank" >RIV/00023001:_____/23:00083895 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/23:10458572 RIV/00216208:11120/23:43925324
Result on the web
<a href="https://www.ahajournals.org/doi/epdf/10.1161/JAHA.122.028987" target="_blank" >https://www.ahajournals.org/doi/epdf/10.1161/JAHA.122.028987</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1161/JAHA.122.028987" target="_blank" >10.1161/JAHA.122.028987</a>
Alternative languages
Result language
angličtina
Original language name
Attenuation of hypocretin/orexin signaling is associated with increased mortality after myocardial infarction
Original language description
BACKGROUND: The hypocretin/orexin system has been shown to play a role in heart failure. Whether it also influences myocar-dial infarction (MI) outcomes is unknown. We evaluated the effect of the rs7767652 minor allele T associated with decreased transcription of the hypocretin/orexin receptor-2 and circulating orexin A concentrations on mortality risk after MI. METHODS AND RESULTS: Data from a single-center, prospectively designed registry of consecutive patients hospitalized for MI at a large tertiary cardiology center were analyzed. Patients without previous history of MI or heart failure were included. A random population sample was used to compare allele frequencies in the general population. Out of 1009 patients (aged 64±12 years, 74.6% men) after MI, 6.1% were homozygotes (TT) and 39.4% heterozygotes (CT) for minor allele. Allele frequencies in the MI group did not differ from 1953 subjects from general population (χ2 P=0.62). At index hospitalization, MI size was the same, but ventricular fibrillation and the need for cardiopulmonary resuscitation were more prevalent in the TT allele variant. Among patients with ejection fraction ≤40% at discharge, the TT variant was associated with a lower increase in left ventricular ejection fraction during follow-up (P=0.03). During the 27-month follow-up, there was a statistically significant association of the TT variant with increased mortality risk (hazard ratio [HR], 2.83; P=0.001). Higher circulating orexin A was associated with a lower mortality risk (HR, 0.41; P<0.05). CONCLUSIONS: Attenuation of hypocretin/orexin signaling is associated with increased mortality risk after MI. This effect may be partially explained by the increased arrhythmic risk and the effect on the left ventricular systolic function recovery. © 2023 The Authors. Published on behalf of the American Heart Association, Inc.,.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of the American Heart Association [online]
ISSN
2047-9980
e-ISSN
2047-9980
Volume of the periodical
12
Issue of the periodical within the volume
6
Country of publishing house
US - UNITED STATES
Number of pages
10
Pages from-to
"art. no. e028987"
UT code for WoS article
000956680700043
EID of the result in the Scopus database
2-s2.0-85150751029